After a Bsc in Biostatics (University of the West of England, Bristol, GB) and a professional license in Biostatistics passed at Joseph Fourier University (Grenoble, France), Aurélia Meurisse became a clinical data manager for Contract Research Organizations (CRO).

After working for 13 years for CRO in Grenoble and Dijon she decided to join the Methodology and quality of life unit in Oncology (UMQVC) at the University hospital of Besancon as a clinical data manager. Her main activities consist in managing data bases for clinical studies promoted by the hospital of Besançon (administrative procedures, data-management activities from creation of case report form to database lock, including data validation and coding of medical terms) and providing support to medical students for their thesis (creation of data bases, data import).

According to her initial training, she punctually produces statistical analysis for Phase II studies (descriptive statistics, survival analysis).

As part of the collaboration with the GERCOR, she provides methodological advices and critical review of documentation related to clinical trials data-management.

Main areas of expertise:

- Clinical data-management

- Meta-bases

Main ongoing external collaborations:

- GERCOR

Tools online

- Flow-chart of data-management process (for clinical studies)

- Data-management process (for medical students) 

Main publications

sample

Background: In advanced pancreatic ductal adenocarcinoma (aPDAC), there is no consensual strategy for second-line...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Journal name : JNCI J Natl Cancer Inst

Latest publications

sample

AbstractBACKGROUND:The benefit of second-line chemotherapy (L2) over standard first-line (L1) gemcitabine plus cisplatin...

Posted by : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Journal name : Eur J Cancer.

sample

We conducted a retrospective study to assess the follow-up of patients with localized breast cancer and the first...

Posted by : , Mme. Aurélia MEURISSE
Journal name : Breast

sample

AbstractBACKGROUND:Specific surgical and oncological outcomes in patients with rectal cancer surgery after a previous...

Posted by : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Journal name : Br J Surg

sample

BACKGROUND:RAS mutations are currently sought for in tumor samples, which takes a median of almost 3 weeks in western...

Posted by : Dr. Dewi VERNEREY, Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Journal name : Ann Oncol

sample

AbstractIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations are currently determined by tumor...

Posted by : Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE
Journal name : Cancers

sample

AbstractBACKGROUND:The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades....

Posted by : Dr. Amélie ANOTA, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Lancet Oncol

sample

AbstractBACKGROUND:The incidence of anal squamous cell carcinoma has been increasing markedly in the past few decades....

Posted by : Dr. Amélie ANOTA, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Lancet Oncol

sample

ABSTRACTBackgroundSunitinib is a tyrosine kinase inhibitor approved in the first-line metastatic renal cell carcinoma...

Posted by : Dr. Guillaume MOUILLET, Mme. Aurélia MEURISSE, Dr. Dewi VERNEREY
Journal name : Trials

sample

Background Nab-paclitaxel plus gemcitabine has become a standard treatment regimen in patients with metastatic...

Posted by : Pr. Franck BONNETAIN, Mme. Aurélia MEURISSE
Journal name : Lancet Gastroenterology Hepatology

sample

ABSTRACTBACKGROUND: Two main therapies, pazopanib and sunitinib, are used in the first-line setting for metastatic renal...

Posted by : Dr. Amélie ANOTA, Pr. Franck BONNETAIN, Dr. Dewi VERNEREY, Mme. Aurélia MEURISSE, , Mme. Astrid POZET, Dr. Sophie PAGET-BAILLY, Mme. Joëlle FRITZSCH, Dr. Guillaume MOUILLET
Journal name : Health and Quality of Life Outcomes

Latest News

Latest tools

Evaluation de la réponse tumorale (Nouveaux critères RECIST v 1.1)“New response evaluation criteria in solid...

Posted by : Mme. Aurélia MEURISSE

Posted by : Mme. Aurélia MEURISSE

2015-2019 © Copyright - UMQVC.org

Website by Pearlweb